SMTL ID : 4bxk.1 (1 other biounit)

Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with a domain-specific inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-FUC.1: 5 residues within 4Å: Chain A: T.478, N.480, T.482, H.483, Y.607 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.480, A:T.482, A:T.482

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.2: 5 residues within 4Å: Chain A: N.45, T.47, E.49, N.50, R.326 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)

NAG-NAG-BMA-FUC.3: 5 residues within 4Å: Chain A: E.403, N.416, E.522, P.524, Q.527 1 PLIP interactions: 1 interactions with chain A Water bridges: A:E.522

3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.4: 2 residues within 4Å: Chain A: W.335 Ligands: 1IU.8 No protein-ligand interaction detected (PLIP) PEG.5: 2 residues within 4Å: Chain A: F.33, R.344 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.344, A:R.344 PEG.6: 5 residues within 4Å: Chain A: W.80, R.96, D.189, G.190, F.191 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.96

1 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)

P6G.7: 9 residues within 4Å: Chain A: F.228, R.231, A.232, R.235, M.267, V.268, V.269, P.270, N.588 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.235, A:R.235

1 x 1IU: [3-[[(2S)-1-azanyl-1-oxidanylidene-propan-2-yl]amino]-2-methyl-3-oxidanylidene-propyl]-[(1R)-1-[[(2R)-2-azanyl-3-(1H-1,2,3,4-tetrazol-5-yl)propanoyl]amino]-2-phenyl-ethyl]phosphinic acid

1IU.8: 19 residues within 4Å: Chain A: Q.259, H.331, A.332, S.333, A.334, H.361, E.362, H.365, Y.369, H.388, E.389, K.489, F.490, H.491, T.496, Y.498, Y.501 Ligands: PEG.4, ZN.9 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:F.490, A:F.490, A:T.496, A:Y.501 Hydrogen bonds: A:Q.259, A:A.334, A:A.334, A:K.489, A:K.489, A:Y.498, A:Y.501 Water bridges: A:G.382, A:E.389, A:R.500, A:R.500, A:Y.501 pi-Stacking: A:H.388

1 x ZN: ZINC ION(Non-covalent)

ZN.9: 4 residues within 4Å: Chain A: H.361, H.365, E.389 Ligands: 1IU.8 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.361, A:H.365, A:E.389

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.10: 5 residues within 4Å: Chain A: Y.202, P.385, P.497, I.499, R.500 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Douglas, R.G. et al., Fragment-Based Design for the Development of N-Domain Selective Angiotensin-1 Converting Enzyme Inhibitors. Clin.Sci. (2014)

Release Date

2013-09-18

Peptides

ANGIOTENSIN-CONVERTING ENZYME: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ANGIOTENSIN-CONVERTING ENZYME

Related Entries With Identical Sequence